The Endotoxemia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Endotoxemia size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Endotoxemia market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Endotoxemia market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Analysis of Cytokines And Cortisol
Analysis of Brain Specific Protein
Electroencephalography
Cognitive Function Tests
Market segment by Application, can be divided into
Hospitals
Ambulatory Surgical Centers (ASCs)
Clinics
Others
Market segment by players, this report covers
LG Life Sciences
GlaxoSmithKline
Exponential Biotherapies
BASF SE
Dupont Danisco
CoMentis
Radboud University
Vienna University of Vienna
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Endotoxemia product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Endotoxemia, with revenue, gross margin and global market share of Endotoxemia from 2019 to 2021.
Chapter 3, the Endotoxemia competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Endotoxemia market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Endotoxemia research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Endotoxemia
1.2 Classification of Endotoxemia by Type
1.2.1 Overview: Global Endotoxemia Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Endotoxemia Revenue Market Share by Type in 2020
1.2.3 Analysis of Cytokines And Cortisol
1.2.4 Analysis of Brain Specific Protein
1.2.5 Electroencephalography
1.2.6 Cognitive Function Tests
1.3 Global Endotoxemia Market by Application
1.3.1 Overview: Global Endotoxemia Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers (ASCs)
1.3.4 Clinics
1.3.5 Others
1.4 Global Endotoxemia Market Size & Forecast
1.5 Global Endotoxemia Market Size and Forecast by Region
1.5.1 Global Endotoxemia Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Endotoxemia Market Size by Region, (2016-2021)
1.5.3 North America Endotoxemia Market Size and Prospect (2016-2026)
1.5.4 Europe Endotoxemia Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Endotoxemia Market Size and Prospect (2016-2026)
1.5.6 South America Endotoxemia Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Endotoxemia Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Endotoxemia Market Drivers
1.6.2 Endotoxemia Market Restraints
1.6.3 Endotoxemia Trends Analysis
2 Company Profiles
2.1 LG Life Sciences
2.1.1 LG Life Sciences Details
2.1.2 LG Life Sciences Major Business
2.1.3 LG Life Sciences Endotoxemia Product and Solutions
2.1.4 LG Life Sciences Endotoxemia Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 LG Life Sciences Recent Developments and Future Plans
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Endotoxemia Product and Solutions
2.2.4 GlaxoSmithKline Endotoxemia Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GlaxoSmithKline Recent Developments and Future Plans
2.3 Exponential Biotherapies
2.3.1 Exponential Biotherapies Details
2.3.2 Exponential Biotherapies Major Business
2.3.3 Exponential Biotherapies Endotoxemia Product and Solutions
2.3.4 Exponential Biotherapies Endotoxemia Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Exponential Biotherapies Recent Developments and Future Plans
2.4 BASF SE
2.4.1 BASF SE Details
2.4.2 BASF SE Major Business
2.4.3 BASF SE Endotoxemia Product and Solutions
2.4.4 BASF SE Endotoxemia Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 BASF SE Recent Developments and Future Plans
2.5 Dupont Danisco
2.5.1 Dupont Danisco Details
2.5.2 Dupont Danisco Major Business
2.5.3 Dupont Danisco Endotoxemia Product and Solutions
2.5.4 Dupont Danisco Endotoxemia Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Dupont Danisco Recent Developments and Future Plans
2.6 CoMentis
2.6.1 CoMentis Details
2.6.2 CoMentis Major Business
2.6.3 CoMentis Endotoxemia Product and Solutions
2.6.4 CoMentis Endotoxemia Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 CoMentis Recent Developments and Future Plans
2.7 Radboud University
2.7.1 Radboud University Details
2.7.2 Radboud University Major Business
2.7.3 Radboud University Endotoxemia Product and Solutions
2.7.4 Radboud University Endotoxemia Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Radboud University Recent Developments and Future Plans
2.8 Vienna University of Vienna
2.8.1 Vienna University of Vienna Details
2.8.2 Vienna University of Vienna Major Business
2.8.3 Vienna University of Vienna Endotoxemia Product and Solutions
2.8.4 Vienna University of Vienna Endotoxemia Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Vienna University of Vienna Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Endotoxemia Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Endotoxemia Players Market Share
3.2.2 Top 10 Endotoxemia Players Market Share
3.2.3 Market Competition Trend
3.3 Endotoxemia Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Endotoxemia Revenue and Market Share by Type (2016-2021)
4.2 Global Endotoxemia Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Endotoxemia Revenue Market Share by Application (2016-2021)
5.2 Endotoxemia Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Endotoxemia Revenue by Type (2016-2026)
6.2 North America Endotoxemia Revenue by Application (2016-2026)
6.3 North America Endotoxemia Market Size by Country
6.3.1 North America Endotoxemia Revenue by Country (2016-2026)
6.3.2 United States Endotoxemia Market Size and Forecast (2016-2026)
6.3.3 Canada Endotoxemia Market Size and Forecast (2016-2026)
6.3.4 Mexico Endotoxemia Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Endotoxemia Revenue by Type (2016-2026)
7.2 Europe Endotoxemia Revenue by Application (2016-2026)
7.3 Europe Endotoxemia Market Size by Country
7.3.1 Europe Endotoxemia Revenue by Country (2016-2026)
7.3.2 Germany Endotoxemia Market Size and Forecast (2016-2026)
7.3.3 France Endotoxemia Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Endotoxemia Market Size and Forecast (2016-2026)
7.3.5 Russia Endotoxemia Market Size and Forecast (2016-2026)
7.3.6 Italy Endotoxemia Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Endotoxemia Revenue by Type (2016-2026)
8.2 Asia-Pacific Endotoxemia Revenue by Application (2016-2026)
8.3 Asia-Pacific Endotoxemia Market Size by Region
8.3.1 Asia-Pacific Endotoxemia Revenue by Region (2016-2026)
8.3.2 China Endotoxemia Market Size and Forecast (2016-2026)
8.3.3 Japan Endotoxemia Market Size and Forecast (2016-2026)
8.3.4 South Korea Endotoxemia Market Size and Forecast (2016-2026)
8.3.5 India Endotoxemia Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Endotoxemia Market Size and Forecast (2016-2026)
8.3.7 Australia Endotoxemia Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Endotoxemia Revenue by Type (2016-2026)
9.2 South America Endotoxemia Revenue by Application (2016-2026)
9.3 South America Endotoxemia Market Size by Country
9.3.1 South America Endotoxemia Revenue by Country (2016-2026)
9.3.2 Brazil Endotoxemia Market Size and Forecast (2016-2026)
9.3.3 Argentina Endotoxemia Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Endotoxemia Revenue by Type (2016-2026)
10.2 Middle East & Africa Endotoxemia Revenue by Application (2016-2026)
10.3 Middle East & Africa Endotoxemia Market Size by Country
10.3.1 Middle East & Africa Endotoxemia Revenue by Country (2016-2026)
10.3.2 Turkey Endotoxemia Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Endotoxemia Market Size and Forecast (2016-2026)
10.3.4 UAE Endotoxemia Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Endotoxemia Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Endotoxemia Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Endotoxemia Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Endotoxemia Revenue (USD Million) by Region (2016-2021)
Table 5. Global Endotoxemia Revenue Market Share by Region (2021-2026)
Table 6. LG Life Sciences Corporate Information, Head Office, and Major Competitors
Table 7. LG Life Sciences Major Business
Table 8. LG Life Sciences Endotoxemia Product and Solutions
Table 9. LG Life Sciences Endotoxemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline Major Business
Table 12. GlaxoSmithKline Endotoxemia Product and Solutions
Table 13. GlaxoSmithKline Endotoxemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Exponential Biotherapies Corporate Information, Head Office, and Major Competitors
Table 15. Exponential Biotherapies Major Business
Table 16. Exponential Biotherapies Endotoxemia Product and Solutions
Table 17. Exponential Biotherapies Endotoxemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. BASF SE Corporate Information, Head Office, and Major Competitors
Table 19. BASF SE Major Business
Table 20. BASF SE Endotoxemia Product and Solutions
Table 21. BASF SE Endotoxemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Dupont Danisco Corporate Information, Head Office, and Major Competitors
Table 23. Dupont Danisco Major Business
Table 24. Dupont Danisco Endotoxemia Product and Solutions
Table 25. Dupont Danisco Endotoxemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. CoMentis Corporate Information, Head Office, and Major Competitors
Table 27. CoMentis Major Business
Table 28. CoMentis Endotoxemia Product and Solutions
Table 29. CoMentis Endotoxemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Radboud University Corporate Information, Head Office, and Major Competitors
Table 31. Radboud University Major Business
Table 32. Radboud University Endotoxemia Product and Solutions
Table 33. Radboud University Endotoxemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Vienna University of Vienna Corporate Information, Head Office, and Major Competitors
Table 35. Vienna University of Vienna Major Business
Table 36. Vienna University of Vienna Endotoxemia Product and Solutions
Table 37. Vienna University of Vienna Endotoxemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Endotoxemia Revenue (USD Million) by Players (2019-2021)
Table 39. Global Endotoxemia Revenue Share by Players (2019-2021)
Table 40. Breakdown of Endotoxemia by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Endotoxemia Players Head Office, Products and Services Provided
Table 42. Endotoxemia Mergers & Acquisitions in the Past Five Years
Table 43. Endotoxemia New Entrants and Expansion Plans
Table 44. Global Endotoxemia Revenue (USD Million) by Type (2016-2021)
Table 45. Global Endotoxemia Revenue Share by Type (2016-2021)
Table 46. Global Endotoxemia Revenue Forecast by Type (2021-2026)
Table 47. Global Endotoxemia Revenue by Application (2016-2021)
Table 48. Global Endotoxemia Revenue Forecast by Application (2021-2026)
Table 49. North America Endotoxemia Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Endotoxemia Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Endotoxemia Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Endotoxemia Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Endotoxemia Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Endotoxemia Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Endotoxemia Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Endotoxemia Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Endotoxemia Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Endotoxemia Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Endotoxemia Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Endotoxemia Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Endotoxemia Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Endotoxemia Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Endotoxemia Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Endotoxemia Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Endotoxemia Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Endotoxemia Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Endotoxemia Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Endotoxemia Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Endotoxemia Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Endotoxemia Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Endotoxemia Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Endotoxemia Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Endotoxemia Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Endotoxemia Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Endotoxemia Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Endotoxemia Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Endotoxemia Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Endotoxemia Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Endotoxemia Picture
Figure 2. Global Endotoxemia Revenue Market Share by Type in 2020
Figure 3. Analysis of Cytokines And Cortisol
Figure 4. Analysis of Brain Specific Protein
Figure 5. Electroencephalography
Figure 6. Cognitive Function Tests
Figure 7. Endotoxemia Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Ambulatory Surgical Centers (ASCs) Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Endotoxemia Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Endotoxemia Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Endotoxemia Revenue Market Share by Region (2016-2026)
Figure 15. Global Endotoxemia Revenue Market Share by Region in 2020
Figure 16. North America Endotoxemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Endotoxemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Endotoxemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Endotoxemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Endotoxemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Endotoxemia Market Drivers
Figure 22. Endotoxemia Market Restraints
Figure 23. Endotoxemia Market Trends
Figure 24. LG Life Sciences Recent Developments and Future Plans
Figure 25. GlaxoSmithKline Recent Developments and Future Plans
Figure 26. Exponential Biotherapies Recent Developments and Future Plans
Figure 27. BASF SE Recent Developments and Future Plans
Figure 28. Dupont Danisco Recent Developments and Future Plans
Figure 29. CoMentis Recent Developments and Future Plans
Figure 30. Radboud University Recent Developments and Future Plans
Figure 31. Vienna University of Vienna Recent Developments and Future Plans
Figure 32. Global Endotoxemia Revenue Share by Players in 2020
Figure 33. Endotoxemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Endotoxemia Revenue Market Share in 2020
Figure 35. Global Top 10 Players Endotoxemia Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Endotoxemia Revenue Share by Type in 2020
Figure 38. Global Endotoxemia Market Share Forecast by Type (2021-2026)
Figure 39. Global Endotoxemia Revenue Share by Application in 2020
Figure 40. Global Endotoxemia Market Share Forecast by Application (2021-2026)
Figure 41. North America Endotoxemia Sales Market Share by Type (2016-2026)
Figure 42. North America Endotoxemia Sales Market Share by Application (2016-2026)
Figure 43. North America Endotoxemia Revenue Market Share by Country (2016-2026)
Figure 44. United States Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Endotoxemia Sales Market Share by Type (2016-2026)
Figure 48. Europe Endotoxemia Sales Market Share by Application (2016-2026)
Figure 49. Europe Endotoxemia Revenue Market Share by Country (2016-2026)
Figure 50. Germany Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Endotoxemia Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Endotoxemia Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Endotoxemia Revenue Market Share by Region (2016-2026)
Figure 58. China Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Endotoxemia Sales Market Share by Type (2016-2026)
Figure 65. South America Endotoxemia Sales Market Share by Application (2016-2026)
Figure 66. South America Endotoxemia Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Endotoxemia Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Endotoxemia Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Endotoxemia Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Endotoxemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source